arrow
M

Mette D. Hazenberg

University of Amsterdam
H指数:38
被引数:7,434

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between oral ulcerative lesions, oral infections, and fever during the pre-engraftment phase after hematopoietic cell transplantation: results from the Orastem study

造血细胞移植后植入前阶段口腔溃疡性病变、口腔感染与发热之间的关联:Orastem研究的结果

2026-10-020
OAAI
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy

2024年EBMT活动报告:完成一百万例HCT和2万例CAR-T。细胞疗法的重要里程碑

2026-05-270
OAAI
An extraction pipeline for analysis of hematopoietic stem cell transplantation data

一种用于分析造血干细胞移植数据的提取流程

2026-03-100
PRE
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines
2025-11-010
OAAI
COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study

COVID-19疫苗在血液系统恶性肿瘤患者中的有效性:一项全国性队列研究

2025-10-010
OAAI
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations

造血细胞移植和CAR-T在血液病、实体瘤和免疫紊乱中的适应证:2025年EBMT实践建议

2025-09-090
OAAI
Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress

推进EBMT内“基础/根本”与转化细胞及基因治疗科学的整合:加速通往进步的路径

2025-08-070
PRE
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT

欧洲异基因造血干细胞移植后供者淋巴细胞输注的当前应用:代表EBMT细胞治疗与免疫生物学工作组进行的调查

2025-03-230
PRE
A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals

在SARS-CoV-2 Omicron感染的免疫功能低下的个体中,强烈的新型冠状病毒 (SARS-CoV-2) 特异性T细胞和b细胞反应与早期病毒清除有关

2024-06-061
OAAI
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study
2024-05-110
OAAI
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors
2024-05-095
OAAI
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

血液系统恶性肿瘤干细胞移植后移植物抗宿主病的预防和管理: 欧洲血液和骨髓移植学会的最新共识建议

2024-02-0131
PRE
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
2024-01-241
OAAI
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

免疫功能低下的血液系统恶性肿瘤患者的第四次mRNA新型冠状病毒肺炎疫苗接种 (COBRA KAI): 一项队列研究

2023-07-018
OAAI